• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71020
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Wound Dehiscence (1154)
Event Date 01/12/2024
Event Type  Injury  
Event Description
Patient was implanted with the nalu peripheral nerve stimulator system on (b)(6) 2023 to treat lower back pain.The system was implanted in the lower back area to target the intercostal nerve.On (b)(6) 2024 the patient presented to the physician's clinic with concern of the implanted device protruding through the skin.Examination found that one of the surgical incision sites had dehisced and the implantable pulse generator (ipg) and implanted leads were exposed.Initial plan was to perform a surgical revision on (b)(6) 2024.Upon initiating the procedure the physician noted the possible presence of infection as well as poor tissue quality in the implant area and elected to fully explant the system at that time.No lab testing has been made available to the firm to confirm or rule out the presence of infection.
 
Manufacturer Narrative
There are no allegations of any failure or malfunction of the nalu system or its components.A suspected infection more than two months post implant is not likely to be caused by the device itself.Additionally, infection was suspected but not confirmed through lab testing.Per the physician, the quality of tissue at the implant site was not adequate to support the device.Inadequate tissue quality likely contributed to the surgical wound dehiscence and implant exposure.Malpositioning of the implant relative to the patient's body makeup appears to be the source of the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
rebecca hess
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18682745
MDR Text Key335072156
Report Number3015425075-2024-00049
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number71020
Device Catalogue Number71020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/02/2023
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-